Ventilator Associated Pneumonia Multiplex PCR for Anti-Infective Regimens
NCT: NCT06554327 · RECRUITING
Brief Summary
Ventilator-associated pneumonia (VAP) remains one of the main nosocomial infections acquired in the intensive care unit (ICU). VAP is pneumonia occurring 48 hours after intubation. Today, bronchoalveolar lavage (BAL) is used for microbiological diagnosis, with bacterial culture and antibiotic susceptibility results within 48 to 72 hours. Multiplex PCR can detect DNA of a number of bacteriae, as well as the presence of resistance genes. However, its clinical value in the ICU remains to be demonstrated. We think that the use of multiplex PCR with a panel adapted to the microbiology of VAP, could be an interesting method for clinicians in ICU.
Frequently Asked Questions
What is Ventilator Associated Pneumonia Multiplex PCR for Anti-Infective Regimens?
Ventilator Associated Pneumonia Multiplex PCR for Anti-Infective Regimens is a clinical trial registered under NCT06554327. Current status: RECRUITING.
What is the status of NCT06554327?
The current status of NCT06554327 (Ventilator Associated Pneumonia Multiplex PCR for Anti-Infective Regimens) is: RECRUITING.
When did Ventilator Associated Pneumonia Multiplex PCR for Anti-Infective Regimens start?
Ventilator Associated Pneumonia Multiplex PCR for Anti-Infective Regimens started on 2025-03-06.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.